The diagnostic role of SARS-CoV-2 in routine respiratory testing after policy adjustment: a real-world laboratory study integrating longitudinal PCR and respiratory pathogen testing workflow data.
- 1Department of Clinical Laboratory, The Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Municipal Central Hospital), Lishui, Zhejiang, China.
- 2Department of Clinical Laboratory, The Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Municipal Central Hospital), Lishui, Zhejiang, China. [email protected].
Abstract
Background
Since COVID-19 entered long-term management, SARS-CoV-2 has become increasingly integrated into routine respiratory diagnostics. However, longitudinal laboratory trends and its relative position within multiplex respiratory pathogen testing remain incompletely described in real-world hospital practice. We characterized SARS-CoV-2 in two complementary diagnostic contexts: longitudinal SARS-CoV-2 PCR testing (Phase A) and multiplex respiratory pathogen testing (Phase B).Methods
We analyzed routine laboratory data from January 2024 to January 2026 to summarize monthly SARS-CoV-2 PCR testing volume and positivity (Phase A). We also analyzed data from the 11-target respiratory PCR testing workflow from January 2025 to January 2026 (Phase B; de-duplicated overall cohort, N = 3,941), with additional analyses in a hospitalized-only subset (n = 3,461). Detection rates were calculated using tested denominators, with multiple pathogens allowed per sample. Under the primary definition, weakly positive results were classified as positive.Results
In Phase A, 19,207 SARS-CoV-2 PCR tests were performed, with an overall positivity rate of 10.43%. Monthly positivity showed recurrent temporal fluctuations, and increases in testing volume did not consistently correspond to higher positivity. In Phase B (overall cohort), human rhinovirus (21.02%) and respiratory syncytial virus (13.71%) were the most frequently detected pathogens, followed by influenza A virus (7.59%). In the hospitalized-only subset, SARS-CoV-2 was detected in 3.90% of samples, ranking fifth among 11 targets. Co-detection of ≥ 2 pathogens occurred in 318/3,941 samples (8.1%); the most frequent pairs were HRV + RSV (2.31%), HRV+adenovirus (1.42%), and HRV+influenza A virus (0.96%).Conclusions
Under post-adjustment routine clinical practice, SARS-CoV-2 showed recurrent fluctuations in longitudinal PCR testing and remained a non-dominant component of the Phase B respiratory pathogen testing workflow. A phase-structured laboratory framework may improve interpretation of routine respiratory diagnostic outputs and support context-aware hospital respiratory pathogen surveillance.
Related
- Diagnostic accuracy of respiratory polygraphy interpretation for pediatric obstructive sleep apnea using a built-in algorithm
- Research protocol for the diagnostic accuracy of intelligent portable impulse oscillometry across different respiratory diseases: a multicentre, cross-sectional study
- Guillain-Barré Syndrome in Late Pregnancy Following Respiratory Syncytial Virus Infection: A Diagnostic Dilemma.
- From respiratory cultures to empirical treatment: Integrating local resistance data, colonization risk, and patient-level factors in hospital-acquired pneumonia
- Umbilical cord blood miR-125b-5p: a diagnostic and prognostic biomarker for neonatal respiratory distress syndrome.
BibTeX
@article{ren2026diagnostic,
title = {{The diagnostic role of SARS-CoV-2 in routine respiratory testing after policy adjustment: a real-world laboratory study integrating longitudinal PCR and respiratory pathogen testing workflow data.}},
author = {Jian-Min Ren and Xiao-Yao Zhang and Xiao-Peng Liu and Hui Ding and Li-Hong Pei and Wei-Ping Jiang and Xiao-Mei Zhang and Jian-Sheng Huang and Xiao-Lei Hu},
journal = {BMC infectious diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-14147-z},
url = {https://europepmc.org/article/MED/42972503},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - The diagnostic role of SARS-CoV-2 in routine respiratory testing after policy adjustment: a real-world laboratory study integrating longitudinal PCR and respiratory pathogen testing workflow data.
AU - Jian-Min Ren
AU - Xiao-Yao Zhang
AU - Xiao-Peng Liu
AU - Hui Ding
AU - Li-Hong Pei
AU - Wei-Ping Jiang
AU - Xiao-Mei Zhang
AU - Jian-Sheng Huang
AU - Xiao-Lei Hu
PY - 2026
DA - 2026/08/05
JO - BMC infectious diseases
DO - 10.1186/s12879-026-14147-z
UR - https://europepmc.org/article/MED/42972503
AB - Background Since COVID-19 entered long-term management, SARS-CoV-2 has become increasingly integrated into routine respiratory diagnostics. However, longitudinal laboratory trends and its relative position within multiplex respiratory pathogen testing remain incompletely described in real-world hospital practice. We characterized SARS-CoV-2 in two complementary diagnostic contexts: longitudinal SARS-CoV-2 PCR testing (Phase A) and multiplex respiratory pathogen testing (Phase B).Methods We analyzed routine laboratory data from January 2024 to January 2026 to summarize monthly SARS-CoV-2 PCR testing volume and positivity (Phase A). We also analyzed data from the 11-target respiratory PCR testing workflow from January 2025 to January 2026 (Phase B; de-duplicated overall cohort, N = 3,941), with additional analyses in a hospitalized-only subset (n = 3,461). Detection rates were calculated using tested denominators, with multiple pathogens allowed per sample. Under the primary definition, weakly positive results were classified as positive.Results In Phase A, 19,207 SARS-CoV-2 PCR tests were performed, with an overall positivity rate of 10.43%. Monthly positivity showed recurrent temporal fluctuations, and increases in testing volume did not consistently correspond to higher positivity. In Phase B (overall cohort), human rhinovirus (21.02%) and respiratory syncytial virus (13.71%) were the most frequently detected pathogens, followed by influenza A virus (7.59%). In the hospitalized-only subset, SARS-CoV-2 was detected in 3.90% of samples, ranking fifth among 11 targets. Co-detection of ≥ 2 pathogens occurred in 318/3,941 samples (8.1%); the most frequent pairs were HRV + RSV (2.31%), HRV+adenovirus (1.42%), and HRV+influenza A virus (0.96%).Conclusions Under post-adjustment routine clinical practice, SARS-CoV-2 showed recurrent fluctuations in longitudinal PCR testing and remained a non-dominant component of the Phase B respiratory pathogen testing workflow. A phase-structured laboratory framework may improve interpretation of routine respiratory diagnostic outputs and support context-aware hospital respiratory pathogen surveillance.
SN - 1471-2334
ER -